Bionano Genomics, Inc.

LSE:0A4K Stock Report

Market Cap: US$5.5m

Bionano Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0A4K?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,1420.185%
Institutions27,7801.63%
VC/PE Firms178,33410.5%
General Public1,490,63487.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 86.5%.

Top Shareholders

Top 25 shareholders own 16.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
Heights Capital Management, Inc.
178,334US$579.6k0%0.18%
1.84%
The Vanguard Group, Inc.
31,335US$101.8k-14.3%no data
0.98%
Geode Capital Management, LLC
16,627US$54.0k13%no data
0.59%
BlackRock, Inc.
10,106US$32.8k-1.27%no data
0.52%
Morgan Stanley, Investment Banking and Brokerage Investments
8,883US$28.9k1,980%no data
0.4%
Jane Street Group, LLC, Asset Management Arm
6,841US$22.2k0%no data
0.26%
Group One Trading LP, Asset Management Arm
4,416US$14.4k17,600%no data
0.21%
Susquehanna International Group, LLP, Asset Management Arm
3,553US$11.5k334%no data
0.16%
Renaissance Technologies LLC
2,638US$8.6k0%no data
0.15%
XTX Holdings Limited, Asset Management Arm
2,621US$8.5k0%no data
0.14%
UBS Asset Management AG
2,415US$7.8k241,000%no data
0.13%
Northern Trust Global Investments
2,268US$7.4k-7.5%no data
0.12%
CARRET Asset Management, LLC
1,983US$6.4k39.9%no data
0.11%
State Street Global Advisors, Inc.
1,850US$6.0k-2.58%no data
0.069%
T. Rowe Price Group, Inc.
1,172US$3.8k0%no data
0.068%
Archford Capital Strategies, LLC
1,159US$3.8k0%no data
0.059%
Robert Holmlin
998US$3.2k8.01%no data
0.043%
Alka Chaubey
737US$2.4k230%no data
0.031%
Mark Oldakowski
528US$1.7k6.02%no data
0.029%
Inspire Advisors, LLC
487US$1.6k-21.6%no data
0.026%
Golden State Equity Advisors, LLC
441US$1.4k0%no data
0.019%
Raymond James Financial Inc., Asset Management Arm
329US$1.1k0%no data
0.017%
Jonathan Dixon
294US$955.8-2%no data
0.017%
Tower Research Capital Europe Limited
286US$929.20.7%no data
0.016%
Mark Adamchak
270US$877.3-1.82%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/23 10:14
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bionano Genomics, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
Kevin DeGeeterOppenheimer & Co. Inc.
Scott HenryRoth Capital Partners